Announcing positive results from a pilot study, shares of Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) have nearly doubled in value on the US stock charts today.
The share price of Virpax Pharmaceuticals Inc. (VRPX) dropped to $4.54 as of the last check in premarket trade, a decline of -12.36%. Virpax shares
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.